Connor, Clark & Lunn Investment Management Ltd. Treace Medical Concepts, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 99,215 shares of TMCI stock, worth $674,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,215
Previous 82,489
20.28%
Holding current value
$674,662
Previous $692,000
15.75%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TMCI
# of Institutions
125Shares Held
40.2MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY6.26MShares$42.6 Million0.64% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$27.7 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.1MShares$21.1 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$18.5 Million0.0% of portfolio
-
Cibc Private Wealth Group, LLC2.29MShares$15.6 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $377M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...